When a biopharmaceutical is developed, the company will typically apply for a patent, which is a grant for exclusive manufacturing rights. This is the primary means by which the developer of the drug can recover the investment cost for development of the biopharmaceutical. The patent laws in the...
Tenaya Therapeuticsis a biopharmaceutical company that develops novel therapies to treat heart diseases. It utilizes its cellular regeneration, gene therapy, and precision medicine product platforms for drug development. Its product pipeline includes TN-201 to treat hypertrophic cardiomyopathy; TN-401 for ...
ApreMilast is a small molecule phosphodiesterase 4 (PDE4) inhibitor developed by Celgene, a US-based biopharmaceutical company. It was approved by the US Food and Drug Administration (FDA) on March 21, 2014, for the treatment of active psoriatic arthritis in adult patients. It is the first ...
Stewart sold close to 4,000 shares of biopharmaceutical company ImClone Systems based on information from Peter Bacanovic, a broker at Merrill Lynch. Bacanovic's tip came after ImClone Systems CEO Samuel Waksal sold all his company shares. This came around when ImClone was waiting on the Food...
The company has Price/Earnings To Growth (PEG) ratio of 0.67. Celgene recorded earning per share (EPS) of 7.32. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 26th of June 2014. Celgene Corporation, a biopharmaceutical company, discovers, develops,...
Nkartaa biopharmaceutical company that discovers, develops and commercialization allogeneic, off-the-shelf engineered natural killer (NK), cell therapies to treat cancer. The company product pipeline includes NKX101, NKX019 (CD19), CD70 and NK+T.Nkartalea...
CytRx Corporation (OTCQB: CYTR) is a biopharmaceutical company with expertise in discovering and developing new therapeutics to treat patients with high unmet needs. CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S Prepares for Regulatory Filing of Arimoclomol in U.S. for Niemann-Pic...
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey. Lianbio ADR ...
Since making this commitment, tech companies have tackled a diverse set of problems. For example, Pfizer used Claudeto assess trends in cancer treatment research after gathering relevant data and scientific content, and Gilead, an American biopharmaceutical company, used...
Such is its reputation that Grifols Engineering provides its services to the wider biopharmaceutical and biotechnology sectors. About Grifols Engineering PRODUCTS AND SERVICES Grifols product portfolio How can we help you? Read more Read more